Surgery, when possible, is the first line treatment for IDH-mutant and 1p/19q-codeleted oligodendroglioma and “watch-and-wait” strategies may be justified in patients with macroscopically complete resection or in young patients (aged < 40 years) with incomplete resection if the tumor is not symptomatic [36]. The gene discussed is IDH1; the disease is neoplasm.